Search results for Biotechnology Industry

BIC calls for ambitious EU Biotech Act II to strengthen European biomanufacturing

BIC has signed a joint position paper stressing that the EU Biotech Act II must be a dedicated and globally ambitious piece of legislation capable of delivering biomanufacturing sc...

Light-Controlled Gene Expression Platform Reportedly Doubles Standard Fed-Batch Manufacturing Performance

The real opportunity lies in next generation complex biologics such as multispecifics, cytokines, and fusion proteins. These molecules represent more than 50% of today's early pipe...

Rethinking the path to IND: How an integrated, global approach can accelerate biologics development

Thermo Fisher’s future US-based option for biologic and sterile fill-finish manufacturing will help to alleviate capacity bottlenecks globally.

<![CDATA[The Evolving Relationship Between FDA and Biotech]]>

Top 10 Pharmaceutical Sectors Set to Boom (2026–2031)

The pharmaceutical industry is entering a new era of hyper-growth, specifically within subsectors powered by next-generation biological and genetic engineering. These fields are cu...

Nod for NextGen Life Sciences Policy

The government has set a target of attracting investments worth $25 billion and generating five lakh jobs in the next five years through the policy.

Plant Molecular Farming Comes of Age

The convergence of advances in biology and digital manufacturing is catapulting plant molecular farming to a scalable, cost-effective position relative to microbial, mammalian, and...

<![CDATA[The Biotech Industry’s Relationship with Real-Time Data: Q&A with Dr. Richard Graham]]>

Bioprocessing Applications Laboratory Opened in Korea by Ecolab Life Sciences

Biomanufacturers across Asia are under increasing pressure to scale with speed. BPAL Korea was created to strengthen its ability to work closely with customers, bringing local expe...

Redefining Bioprocessing Using Reservoirs of Biochemical Diversity

Scientists exploring Saudi Arabia’s desert soils have discovered resilient microbial enzymes that could transform drug manufacturing. These glycosyltransferases, shaped by extreme...

Coalition of Biotechnology Companies Launch American Biotech Innovation Alliance

On May 5, 2025, a coalition of U.S. biotechnology companies announced the launch of the American Biotech Innovation Alliance (ABIA). ABIA states that it will “focus on a shared obj...

CPC Biotech Launched to Offer a Fluid Management Component Portfolio

CPC Biotech’s solutions support a range of applications in bioprocessing operations, spanning the upstream and downstream biologic drug manufacturing process, as well as cell and g...

EU Biotech Act: The European Commission’s landmark proposal to strengthen biotechnology in Europe

In December 2025, the European Commission published its proposal for the European Biotech Act. The proposal is a centerpiece of the Commission's broader strategy to position the EU...

Biotech Firm Says It Can Cut Gene Therapy Production Time To One Day

A key claim by the company MedTherapy is a major reduction in production timelines. While gene therapies typically take weeks or months to manufacture, MedTherapy says it has signi...

This Startup Aims to Upend Biologic Drug Production With Implantable ‘Cell Factories’

Duracyte’s implants employ cells engineered to produce therapeutic protein, bypassing the complexities of traditional biologics manufacturing. The startup’s marriage of biotechnolo...

Three-year biotech policy drafted

Policy designed to enhance agricultural output, adopt global farming practices

<![CDATA[Industrializing Machine Learning and Artificial Intelligence in Life Sciences]]>

US Investments Intended To Take Indian Pharma Up The Value Chain: Interview

This is the first time such huge investments are being made. The Indian pharmaceutical industry has grown from small companies into multinational corporations. Out of the top 20 gl...

Alamar Biosciences files for IPO amid opening life sciences funding window

Californian protein sequencing company Alamar Biosciences is seeking an IPO worth up to $159 million amid a growing boom in life sciences public offerings.

Biologics CDMO Market 2026: Who’s Winning, What’s Driving Growth, and Should You Buy the Report?

The Biologics CDMO Market is rapidly transforming the pharmaceutical and biotech landscape. As drug developers increasingly outsource complex biologics manufacturing, Contract Deve...

<![CDATA[Lessons Learned in the Current Biotech Funding Environment]]>

<![CDATA[The Relationship Between the Capital Markets and Biotech?]]>

The biggest biotech funding rounds in March 2026

The companies Earendil Labs, Teva Pharmaceuticals, and Solid Biosciences bagged the biggest biotech funding rounds overall in March 2026. The post The biggest biotech funding round...

Executing Biologics Technology Transfer through Integrated Operating Models

As biologics modalities diversify and processes grow complex, the success of tech transfer depends on integrated execution rather than each procedural completion. The post Executin...